Opening Bell Analyst Calls Briefing for Friday, November 4, 2022
Here are Friday's final analyst research calls before the opening bell.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> TPI Composites (TPIC) upgraded to Buy from Hold at Craig Hallum; tgt $17
> Verbund AG (OEZVY) upgraded to Hold from Sell at Stifel
Downgrades:
> Atlassian (TEAM) downgraded to Neutral from Outperform at Macquarie; tgt lowered to $147
> Autohome (ATHM) downgraded to Neutral from Buy at CCB International; tgt $43.35
> Canadian Natrl Res (CNQ) downgraded to Buy from Action Buy List at TD Securities
> Fidelity Nat’l Info (FIS) downgraded to Peer Perform from Outperform at Wolfe Research
> GoPro (GPRO) downgraded to Perform from Outperform at Oppenheimer
> Medifast (MED) downgraded to Neutral from Buy at DA Davidson; tgt lowered to $106
> Spin Master (SNMSF) downgraded to Hold from Buy at TD Securities
> Teva Pharma (TEVA) downgraded to Sell from Neutral at UBS
> Trinity Capital (TRIN) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt lowered to $12.50
Others:
> Enovix (ENVX) initiated with a Buy at Janney; tgt $23
> Fate Therapeutics (FATE) assumed with an Overweight at Cantor Fitzgerald; tgt lowered to $45
Research calls posted earlier this morning are available here and here.
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.